Main
>
ONCOLOGY (**)
>
Leukemia>Myeloid>Acute>IDH1+ R/R
>
Treatment
>
FR. S. Ivosidenib 250 mg Tab.
>
Patent>UpDate: 2018. 07.17.
Patent>UpDate: 2018. 07.17.'s products
This section has no products